Lecanemab (Mouse IGG2a)
Product Specifications
UNSPSC Description
Lecanemab (Mouse IGG2a) is a monoclonal antibody that targets soluble β-amyloid and has the potential to reduce cognitive decline. The variable region of Lecanemab (Mouse IGG2a) is consistent with that of Lecanemab, while the constant region is of Mouse IGG2a sequence. Lecanemab (Mouse IGG2a) holds promise for research in the field of Alzheimer's disease[1].
Target Antigen
Amyloid-β
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lecanemab-mouse-igg2a.html
Purity
99.00
Smiles
[Lecanemab (Mouse IGG2a)]
References & Citations
[1]Vitek GE, et al. Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. Expert Opin Investig Drugs. 2023 Feb;32(2):89-94.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P990110/Lecanemab-Mouse-IGG2a-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P990110/Lecanemab-Mouse-IGG2a-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7066847 Inquire
Recombinant Fagopyrum esculentum subsp. ancestrale Photosystem II CP47 chlorophyll apoprotein (psbB), partial
Ask
View Details 
